Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 10.46 | 10.46 | 10.46 | 9.51 | 9.51 |
Reserves | 1,802.18 | 1,514.79 | 1,281.52 | 1,097.65 | 990.16 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,812.64 | 1,525.25 | 1,291.98 | 1,107.16 | 999.67 |
Secured Loans | 0.38 | 6.23 | 31.24 | 60.59 | 86.35 |
Unsecured Loans | 2.59 | 3.51 | 0.31 | 1.91 | 2.93 |
Total Debt | 2.97 | 9.74 | 31.55 | 62.50 | 89.28 |
Other Liabilities | 2.82 | 1.96 | 2.30 | 1.87 | 2.10 |
Total Liabilities | 1,818.43 | 1,536.95 | 1,325.83 | 1,171.53 | 1,091.05 |
APPLICATION OF FUNDS : | |||||
Gross Block | 1,095.41 | 825.51 | 791.69 | 719.94 | 644.29 |
Less: Accumulated Depreciation | 300.73 | 250.20 | 198.71 | 146.97 | 98.08 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 794.68 | 575.31 | 592.98 | 572.97 | 546.21 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 50.66 | 211.48 | 172.70 | 74.16 | 17.95 |
Investments | 335.20 | 244.37 | 137.72 | 74.39 | 141.65 |
Current Assets, Loans & Advances | |||||
Inventories | 239.67 | 207.95 | 212.31 | 195.12 | 153.61 |
Sundry Debtors | 521.65 | 349.61 | 273.76 | 232.17 | 177.52 |
Cash and Bank Balance | 1.18 | 47.02 | 43.45 | 88.93 | 60.82 |
Loans and Advances | 56.20 | 47.94 | 61.25 | 42.97 | 74.22 |
Total Current Assets | 818.70 | 652.53 | 590.77 | 559.19 | 466.16 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 166.06 | 124.91 | 128.91 | 119.21 | 73.68 |
Provisions | 15.67 | 9.40 | 36.47 | 1.75 | 0.66 |
Total CL & Provisions | 181.73 | 134.30 | 165.39 | 120.96 | 74.34 |
Net Current Assets | 636.97 | 518.23 | 425.39 | 438.23 | 391.82 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 4.13 | 2.45 | 2.18 | 1.95 | 0.60 |
Deferred Tax Liability | 38.15 | 30.52 | 25.62 | 22.92 | 18.05 |
Net Deferred Tax | -34.02 | -28.07 | -23.44 | -20.97 | -17.45 |
Other Assets | 34.94 | 15.62 | 20.48 | 32.74 | 10.87 |
Total Assets | 1,818.43 | 1,536.95 | 1,325.83 | 1,171.52 | 1,091.05 |
Contingent Liabilities | 3.91 | 14.31 | 14.31 | 13.32 | 3.89 |